Wegovy Pen Dose Splitting
Splitting a 2.4 mg Wegovy (semaglutide) pen to create ten 0.25 mg doses is not recommended because the pen is for 1-time use only and the dose is already set on the pen. [1]
Manufacturer Instructions for Wegovy Pens
The Wegovy pen is for subcutaneous use only. [1] The Wegovy pen is for 1-time use only. [1] The dose of Wegovy is already set on the pen. [1] The injection cannot be paused and restarted later. [1]
Implications for Creating 0.25 mg Doses
A 2.4 mg pen is calibrated to deliver the preset 2.4 mg dose for once-weekly administration. [1] Creating partial weekly doses by dividing the contents is inconsistent with the device instructions. [1]
Recommended Dose Adjustment Pathway
The labeled alternative to administering a lower dose is to use an appropriately dosed Wegovy pen strength that matches the prescribed dose (for example, the 0.25 mg pen for the lower-dose step). [2] If intolerance occurs at a dose during escalation, the prescribing information supports delaying dose escalation for 4 weeks rather than modifying pen contents. [3]
Safety Considerations
Medication dosing errors with semaglutide products have been reported, including overdoses related to incorrect dose conversion calculations. [4] Use of a split or repackaged pen increases dosing error risk because the device is not designed for subdivision. [1], [4]
Practical Recommendation for This Scenario
A 2.4 mg Wegovy pen should not be divided into ten 0.25 mg doses. [1] The prescribed lowest weekly dose should be obtained using the correct Wegovy pen strength or via a prescriber-directed adjustment to the dosing schedule. [2], [3]